India’s Pharma Industry: A History of Innovation and Global Impact

India’s pharmaceutical sector has transformed into a global powerhouse, renowned for its cost-effective, high-quality medicines. Starting from the mid-20th century, India focused on building a solid pharmaceutical base to cater to its domestic needs. Over time, it emerged as a key player in producing generic drugs, gaining the title "pharmacy of the world." Today, India meets 20% of the global demand for generics and manufactures over 60,000 different brands across various therapeutic areas.

One of India’s standout achievements is its vaccine production. As the world’s largest vaccine manufacturer, India supplies vaccines to over 150 countries. Its facilities handle 60% of the global vaccine needs, including 70% of the WHO's essential vaccines like DPT, BCG, and measles. This immense production capacity makes India indispensable in the global fight against infectious diseases, relying on its efficient logistics to deliver vaccines worldwide at affordable prices.

Additionally, India’s contract research and manufacturing services (CRAMS) industry is expanding rapidly. The country’s skilled workforce has made it a hub for pharmaceutical innovation, especially in biosimilars and biologics, where it leads globally. The industry’s growth is supported by government initiatives, including 100% Foreign Direct Investment (FDI) and the Production Linked Incentive (PLI) scheme, positioning India’s pharma sector for significant expansion to $130 billion by 2030.

For the pharmaceutical logistics industry, India’s role offers lucrative opportunities. Engaging with India’s robust pharma sector and its global distribution network presents a chance to participate in a vital, high-growth industry while ensuring efficient and cost-effective global transport of life-saving medicines.

What is your opinion? How do you do your business with India?

Connect with us at www.ipharmalogistics.com